As reported by GuruFocus Real Time Picks yesterday,
cut his position in
by nearly 20%. Despite his sell, Icahn still remains the largest
guru shareholder of WebMD stock.
On Sept. 17 Icahn reduced his holdings in WebMD by 17.51% by
selling a total of 1,173,092 shares of the company's stock. He sold
these shares at an average price of $31.23 per share, bringing in
over $36.6 million as a result of this transaction.
Icahn's sell of these shares represents his first transaction in
the company since the first quarter of 2012. After this sell, Icahn
holds on to 5,527,433 shares of WebMD stock, representing 10.97% of
the company's shares outstanding.
Icahn's holding history as of the close of the second quarter:
WebMD is a provider of health information services, serving
consumers, physicians, healthcare professionals, employers and
health plans through their public and private online portals,
mobile platforms and health-focused publications.
WebMD's historical pricing:
The company recently announced a new version of its market-leading
app for the iPhone. The app will include personalized and engaging
multimedia lifestyle content. The company claims that "it is the
latest milestone in WebMD's commitment to create and deliver the
most engaging health content based on the unique health needs and
interests of each user."
On Sept. 11, WebMD announced the preliminary results of its tender
offer to purchase up to 5 million shares of its common stock at a
price of $34.00 per share. Based on the preliminary count by
American Stock Transfer & Trust Company, the depository for the
tender offer, approximately 28.5 million shares of common stock
were tendered and not withdrawn. Since the offer was
oversubscribed, the number of shares that WebMD will purchase from
each tendering shareholder will be pro-rated. Based upon the
preliminary count, WebMD estimates that the pro-ration factor will
be approximately 18%.
As of Sept. 10, the company had approximately 50.8 million shares
of common stock outstanding, and after the transaction goes
through, the company expects to have 45.8 million shares
outstanding and $880 million in cash and cash equivalents.
WebMD's historical revenue and net income:
It's also interesting to note that alongside Icahn, chairman of the
board of WebMD, Martin Wygod, also sold a significant 185,938
shares yesterday. The company had not seen much insider activity
over the past year up until the middle of July when several
insiders began selling shares.
As seen in the chart above, several insiders began selling shares
of WebMD as the company's price rebounded to hit and exceed its
The GuruFocus analysis on WebMD reports that the company's price is
at a one-year high, its P/E ratio is nearing a 10-year high and its
P/S ratio is also close to a one-year high.
WebMD is held by three big gurus:
1. Carl Icahn: 5,527,433 shares, representing 10.97% of the
company's shares outstanding.
2. Steven Cohen: 2,597,194 shares, representing 5.15% of the
company's shares outstanding.
3. Jim Simons: 182,180 shares, representing 0.36% of the company's
WebMD has a market cap of $1.54 billion. Its shares are currently
trading at around $30.48 with a P/E ratio of 713.30, a P/S ratio of
713.30 and a P/B ratio of 3.00.About GuruFocus: GuruFocus.com
tracks the stocks picks and portfolio holdings of the world's best
investors. This value investing site offers stock screeners and
valuation tools. And publishes daily articles tracking the latest
moves of the world's best investors. GuruFocus also provides
promising stock ideas in 3 monthly newsletters sent to